201 related articles for article (PubMed ID: 3061836)
21. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
[TBL] [Abstract][Full Text] [Related]
22. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
[TBL] [Abstract][Full Text] [Related]
23. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
Rai KR; Davey F; Peterson B; Schiffer C; Silver RT; Ozer H; Golomb H; Bloomfield CD
Leukemia; 1995 Jul; 9(7):1116-20. PubMed ID: 7630181
[TBL] [Abstract][Full Text] [Related]
24. Early response to alpha interferon in a patient affected by hairy cell leukemia.
Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
[TBL] [Abstract][Full Text] [Related]
25. Alpha interferon treatment of patients with hairy-cell leukaemia.
Hagberg H; Alm G; Björkholm M; Glimelius B; Killander A; Simonsson B; Sundström C; Ahre A
Scand J Haematol; 1985 Jul; 35(1):66-70. PubMed ID: 4048862
[TBL] [Abstract][Full Text] [Related]
26. Hairy cell leukemia. Current management.
Doane LL; Ratain MJ; Golomb HM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):489-502. PubMed ID: 2182604
[TBL] [Abstract][Full Text] [Related]
27. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
28. [Low-dose alpha-interferon treatment of hairy cell leukemia].
von Wussow P; Freund M; Block B; Diedrich H; Schmoll H; Poliwoda H; Deicher H
Klin Wochenschr; 1987 Jul; 65(14):681-4. PubMed ID: 3626433
[TBL] [Abstract][Full Text] [Related]
29. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
[TBL] [Abstract][Full Text] [Related]
30. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
[TBL] [Abstract][Full Text] [Related]
31. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
[TBL] [Abstract][Full Text] [Related]
32. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
[TBL] [Abstract][Full Text] [Related]
33. Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell Leukemia.
Federico M; Chisesi T; Lauria F; Bernasconi C; Capnist G; Castoldi G; Damasio E; Pagnucco G; Frassoldati A; Resegotti L
Br J Haematol; 1989 May; 72(1):54-6. PubMed ID: 2660901
[TBL] [Abstract][Full Text] [Related]
34. Response to intermediate and standard doses of IFN-beta in hairy-cell leukaemia.
Liberati AM; Fizzotti M; Di Clemente F; Senatore M; Berruto P; Falini B; Martelli MF; Grignani F
Leuk Res; 1990; 14(9):779-84. PubMed ID: 2232850
[TBL] [Abstract][Full Text] [Related]
35. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
36. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
[TBL] [Abstract][Full Text] [Related]
37. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukaemia: evaluation of response and maintenance dose.
Nielsen B; Braide I
Eur J Haematol; 1992 Oct; 49(4):174-9. PubMed ID: 1343089
[TBL] [Abstract][Full Text] [Related]
38. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
39. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon.
Naeim F; Jacobs AD
Hum Pathol; 1985 Dec; 16(12):1200-5. PubMed ID: 4065882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
